Hyperion Defi (HYPD) Amortizatization of Intangibles (2022 - 2026)
Hyperion Defi (HYPD) posted quarterly Amortizatization of Intangibles of $55461.0 for Q1 2026, down 80.05% year-over-year from $277972.0 in Q1 2025, and down 80.05% quarter-over-quarter from $277972.0 in Q1 2025.
Hyperion Defi (HYPD) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Amortizatization of Intangibles for 5 consecutive years, with $55461.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 80.05% year-over-year to $55461.0; the TTM figure through Mar 2026 stood at $724069.0 (down 15.1% YoY), while the FY2025 annual figure was $655997.0, down 13.58% from the prior year.
- Amortizatization of Intangibles eased to $55461.0 in Q1 2026 per HYPD's latest filing, from $277972.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $277972.0 in Q1 2025 and bottomed at -$16359.0 in Q4 2022.
- Historically, Amortizatization of Intangibles has averaged $131187.8 across 5 years, with a median of $174081.0 in 2023.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles soared 1226.02% — and 2026, when it plunged 80.05%.
- Hyperion Defi's Amortizatization of Intangibles stood at -$16359.0 in 2022, then jumped by 1226.02% to $184206.0 in 2023, then gained by 12.06% to $206429.0 in 2024, then surged by 34.66% to $277972.0 in 2025, then slumped by 80.05% to $55461.0 in 2026.
- Business Quant data shows HYPD's Amortizatization of Intangibles at $55461.0 in Q1 2026, $277972.0 in Q1 2025, and $206429.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 | 55,460.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55,460.00 |
| Jun 30, 2026 | 55,460.00 |
| Mar 31, 2026 | 55,461.00 |
| Mar 31, 2026 | 55,461.00 |
| Mar 31, 2025 | 277,972.00 |
| Mar 31, 2025 | 277,972.00 |
| Dec 31, 2024 | 206,429.00 |
| Dec 31, 2024 | 206,429.00 |
| Sep 30, 2024 | 184,207.00 |
| Sep 30, 2024 | 184,207.00 |
| Jun 30, 2024 | 184,207.00 |
| Jun 30, 2024 | 184,207.00 |
| Mar 31, 2024 | 184,207.00 |
| Mar 31, 2024 | 184,207.00 |
| Dec 31, 2023 | 184,206.00 |
| Dec 31, 2023 | 184,206.00 |
| Sep 30, 2023 | 184,208.00 |
| Sep 30, 2023 | 184,208.00 |
| Jun 30, 2023 | 163,956.00 |
| Jun 30, 2023 | 163,956.00 |